Adherence: latest news

Adherence resources

  • Drug resistance

    It's important to always take your HIV treatment at the right times and in the right amounts. If you don't, HIV may become drug resistant.When...

    From: The basics

    Information level Level 1
  • An HIV treatment journey

    This illustrated leaflet shows the journey a lot of people go on with HIV treatment. However, each person’s situation is different. Your own circumstances may...

    From: The basics

    Information level Level 1
  • Taking drugs on time

    For HIV treatment to work well, you need to always take your pills at the right time, without missing any doses.Taking anti-HIV drugs regularly will...

    From: The basics

    Information level Level 1
  • Your diet and anti-HIV drugs

    Choosing a drug combination that you can fit into your existing eating habits is usually easier than trying to adjust your eating habits to fit the drugs. There...

    From: Booklets

    Information level Level 2
  • Travelling with HIV medications – time zone changes

    Travelling to a new time zone may affect when it’s best to take your medication.If you have an undetectable viral load, taking one dose a few hours...

    From: Factsheets

    Information level Level 2
  • Why taking your HIV treatment properly is so important

    The currently available anti-HIV drugs cannot cure HIV. However, treatment with a combination of these drugs (usually three) can reduce the amount of HIV in your blood (your...

    From: Booklets

    Information level Level 2
  • What does taking your HIV treatment involve?

    Taking your drugs as prescribed is often called ‘adherence’. Adherence to your HIV treatment means: Taking all the medicines that make up your...

    From: Booklets

    Information level Level 2
  • Factors that can affect adherence

    Medicines from the three main classes of anti-HIV drugs (nucleoside reverse transcriptase inhibitors or NRTIs; non-nucleoside reverse transcriptase inhibitors or NNRTIs; and protease inhibitors) are available in forms...

    From: Booklets

    Information level Level 2
  • Taking your HIV treatment

    This booklet is a starting point for anyone who wants to know about treatment for HIV. It provides basic information about how HIV treatment works...

    From: Booklets

    Information level Level 2
  • Adherence

    Taking your medication exactly as prescribed is key to HIV treatment working.As treatment is a long-term commitment, it’s important that your treatment suits your lifestyle.If you find...

    From: Factsheets

    Information level Level 2
  • Adherence tips

    You may find that a pill box, a phone alarm or a diary helps you with adherence.Adherence can be more challenging when travelling or when routines are...

    From: Factsheets

    Information level Level 2
  • Adherence

    Information on adherence to anti-HIV drugs, including advice on how patients can maintain adherence to their therapy and how healthcare providers can help....

    From: HIV treatments directory

    Information level Level 4

Adherence features

Adherence in your own words

Adherence news from aidsmap

More news

Adherence news selected from other sources

  • Behavioral Therapy Provides Depression and Adherence Benefits in HIV Study

    Four months of cognitive behavioral therapy for depression and antiretroviral adherence significantly improved adherence and depression scores when compared with treatment as usual in a three-way randomized trial involving adults with HIV infection. Relative improvements in adherence and depression held up in the eight months after the interventions ended.

    30 November 2016 | The Body Pro
  • UNC Receives $18 Million to Combine Tech & Health

    "iTech will be home to six studies with each study using technology to address a barrier to the HIV care continuum,” said Hightow-Weidman. “For youth at risk of becoming infected with HIV, we will develop apps that list HIV testing sites and medical providers who prescribe pre-exposure prophylaxis or PrEP to prevent HIV. For youth who test positive for the virus, we will develop electronic health interventions to engage them in care and improve adherence to antiretroviral therapy.”

    28 September 2016 | University of North Carolina Institute for Global Health & Infectious Diseases
  • Four day a week ART: sub-optimal drug levels but few virological failures

    A poster at IAS 2016 reported on the effectiveness of a strategy in France to use reduced dose maintenance therapy. This involved only taking ART for four rather than seven days a week.

    20 September 2016 | HIV i-Base
  • Smartphone app could help high-risk HIV men stay on their meds

    Dworkin created the app by gathering African-American HIV-infected men who have sex with men in focus groups and discussing the common treatment questions they wanted answers to and the appropriate language the app should use in responding.

    21 July 2016 | Science Magazine
  • People who use drugs still adherent to PrEP

    New research conducted with a group of PrEP clients at the San Francisco AIDS Foundation PrEP clinic suggests that people who use substances adhere to PrEP and stay in care at about the same rate as people who do not use drugs.

    13 April 2016 | BETA blog
  • Adherence State of Mind

    Tom Hayes writes: "As someone with near flawless adherence for the last four years I was shocked when I recently fell off the rails. It seems none of us are perfect."

    18 February 2016 | Beyond Positive
  • Four Skills You Need to Successfully Manage Your HIV

    Chronic illnesses can impact anyone, the secret is to manage yours. And to do that you need some specific skills. The people who are the most successful at managing their disease often do so by thinking of their illness as a journey or a hike down a path.

    24 January 2016 | Huffington Post Canada
  • IV and Injectable HIV Treatments Are Much Discussed -- But Won't Be Here Anytime Soon

    Given the success of currently available oral therapies -- in which essentially 100% of people who take it are virologically suppressed -- why do so many people say they want injectable shots instead?

    21 January 2016 | TheBody Pro
  • Antiretroviral Drugs Fail to Consistently Reach Patients in Countries Most Affected By HIV/Aids

    MSF today warned that life-saving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa - most often despite sufficient stocks already being present in countries - and called for urgent improvements in ARV supply chains in the region.

    30 November 2015 | MSF press release
  • Can’t Swallow a Pill? There’s Help for That

    “Age doesn’t really impact your ability to swallow a pill,” said Dr. Kathleen Bradford, a professor of pediatrics at the University of North Carolina at Chapel Hill. “A teenager can have just as many problems as a 5-year-old. It likely has to do with anxiety and the negative associations with swallowing a pill.”

    22 September 2015 | New York Times
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.